There are 68 papers on circulating tumor DNA in aging research: 9 observational studies in people, 1 in cells, 58 reviews.
13 new papers in 30 daysSee all 85 papers on circulating tumor DNA
“Clinical testing demonstrates an area under the curve (AUC) of 0.97 for ctDNA detection in CRC patients.”
- Humans9
- Cells1
Upstream
1Clonal hematopoiesis clone size
no changein humans1
1 study
Clonal hematopoiesis clone size
no changein humans1
Clonal hematopoiesis clone size was not clearly linked with circulating tumor DNA in humans (High-risk primary large B-cell lymphoma).
HumansHigh-risk primary large B-cell lymphoma
Associations
7Colorectal cancer
upin humans2
2 studies
Colorectal cancer
upin humans2
Circulating tumor DNA predicts colorectal cancer in humans (for early CRC detection in asymptomatic adults) (sensitivity 0.887, specificity 0.913).
Reviewfor early CRC detection in asymptomatic adults
Circulating tumor DNA predicts colorectal cancer in humans (invasive colorectal cancer screening) (AUC 0.92, sensitivity 0.72, specificity 0.91).
Reviewinvasive colorectal cancer screening
MASD-seq
upin humans1
1 study
MASD-seq
upin humans1
MASD-seq predicts circulating tumor DNA in CRC patients (AUC 0.97).
Humansin CRC patients
Disease recurrence
upin humans1
1 study
Disease recurrence
upin humans1
Circulating tumor DNA predicts disease recurrence in humans (colorectal cancer).
Reviewcolorectal cancer
Advanced precancerous lesions
upin humans1
1 study
Advanced precancerous lesions
upin humans1
Circulating tumor DNA predicts advanced precancerous lesions in humans (advanced precancerous lesions screening) (sensitivity 0.13 (95% CI 0.12-0.14), specificity 0.90 (95% CI 0.88-0.91)).
Reviewadvanced precancerous lesions screening
Tumor burden and treatment response monitoring
mixedin humans1
1 study
Tumor burden and treatment response monitoring
mixedin humans1
Circulating tumor DNA predicts tumor burden and treatment response monitoring in humans (gastrointestinal cancers).
Reviewgastrointestinal cancers
Colorectal cancer recurrence
upin humans1
1 study
Colorectal cancer recurrence
upin humans1
Circulating tumor DNA predicts colorectal cancer recurrence in humans After treatment of localized colorectal cancer.
ReviewAfter treatment of localized colorectal cancer
Recurrence
upin humans1
1 study
Recurrence
upin humans1
Circulating tumor DNA predicts Recurrence in humans (primary or adjuvant therapy for HCC).
Reviewprimary or adjuvant therapy for HCC
Funding
7 grants since 2017National Cancer Institute$3.3MAmerican Cancer Society1.2MOffice of the President, University of California$98.8K
National Cancer InstituteH. Lee Moffitt Cancer Ctr & Res Inst$664K2021–2027
Optimizing detection of circulating tumor DNA for lung cancer screening
American Cancer SocietyStanford University792K2022–2025
MSI Detection in Circulating Tumor DNA of Lynch Syndrome Patients
American Cancer SocietyMemorial Sloan Kettering Cancer Center437K2022–2024
Characterization of Smoking-Associated Circulating Tumor DNA (ctDNA) for Lung Cancer
Office of the President, University of CaliforniaUniversity of California Los Angeles$49.4K2019
Characterization of Smoking-Associated Circulating Tumor DNA (ctDNA) for Lung Cancer
Office of the President, University of CaliforniaUniversity of California Los Angeles$49.4K2019–2021
Establishment of Japan circulating tumor DNA cancer screening panel
Japan Society for the Promotion of ScienceJapanese Foundation for Cancer Research¥4.2M2018–2020
Gene fusion discovery and circulating tumor DNA detection in upper aerodigestive system cancers
VetenskapsrådetKarolinska InstitutetSEK 6M2017–2020